# Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

> **NCT00699023** · PHASE4 · COMPLETED · sponsor: **Federico II University** · enrollment: 13 (estimated)

## Conditions studied

- Postprandial Lipemia
- Type 2 Diabetes

## Interventions

- **DRUG:** ezetimibe tablets
- **DRUG:** simvastatin tablets
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00699023
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2009-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699023, "Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00699023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*